Genetic Signatures Ltd. (AU:GSS) has released an update.
Genetic Signatures Limited has announced that Dr. Anthony Radford ceased to be a director of the company as of August 22, 2024. Prior to his departure, Dr. Radford held 323,530 fully paid ordinary shares in the company. The disclosure, made in compliance with ASX listing rules, reveals no further director’s interests in securities, nor any involvement in contracts at the time of his exit.
For further insights into AU:GSS stock, check out TipRanks’ Stock Analysis page.